Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

platinum resistance

  • Open Access
    Association of UBE2L6 and ABCB6 Expression With Platinum Resistance in Serous Ovarian Carcinoma
    MAMI SHIBAHARA, TOMOKO KURITA, MIDORI MURAKAMI, HIROSHI HARADA, CHIHO KOI, HIROTO IZUMI and KIYOSHI YOSHINO
    Anticancer Research August 2023, 43 (8) 3787-3792; DOI: https://doi.org/10.21873/anticanres.16564
  • You have access
    Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG
    Anticancer Research January 2022, 42 (1) 349-353; DOI: https://doi.org/10.21873/anticanres.15492
  • You have access
    Applicability of the Histoculture Drug Response Assay to Predict Platinum Sensitivity and Prognosis in Ovarian Cancer
    JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG
    Anticancer Research December 2021, 41 (12) 6287-6292; DOI: https://doi.org/10.21873/anticanres.15450
  • You have access
    Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports
    SHU SOEDA, TAKAFUMI WATANABE, NORIHITO KAMO, TETSU SATO, CHIKAKO OKABE, MAKIKO UEDA, YUTA ENDO, KOJIMA MANABU, SHINJI NOMURA, SHIGENORI FURUKAWA, HIDEKAZU NISHIGORI, TOSHIFUMI TAKAHASHI and KEIYA FUJIMORI
    Anticancer Research September 2020, 40 (9) 5263-5270; DOI: https://doi.org/10.21873/anticanres.14530
  • You have access
    Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer
    ANNE WENG EKMANN-GADE, CLAUS KIM HOGDALL, SVEND AAGE ENGELHOLM and CARSTEN LINDBERG FAGO-OLSEN
    Anticancer Research May 2020, 40 (5) 2765-2770; DOI: https://doi.org/10.21873/anticanres.14248
  • You have access
    Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition
    MORIKAZU MIYAMOTO, MASASHI TAKANO, TADASHI AOYAMA, HIROAKI SOYAMA, HIROKI ISHIBASHI, KENTO KATO, HIDEKI IWAHASHI, KAZUKI TAKASAKI, MIKA KUWAHARA, HIROKO MATUURA, TAKAHIRO SAKAMOTO, TOMOYUKI YOSHIKAWA and KENICHI FURUYA
    Anticancer Research January 2018, 38 (1) 301-306;
  • You have access
    Cancer Stem Cell Properties as Factors Predictive of Chemoresistance in Neoadjuvantly-treated Patients with Ovarian Cancer
    MARJO PYLVÄS-EEROLA, ANNIKKI LIAKKA, ULLA PUISTOLA, JUSSI KOIVUNEN and PEETER KARIHTALA
    Anticancer Research July 2016, 36 (7) 3425-3431;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire